Professional Documents
Culture Documents
HEARING
BEFORE THE
SUBCOMMITTEE ON HEALTH
OF THE
SUBCOMMITTEE ON HEALTH
BILL THOMAS, California, Chairman
NANCY L. JOHNSON, Connecticut FORTNEY PETE STARK, California
JOHN MCCRERY, Louisiana BENJAMIN L. CARDIN, Maryland
JOHN ENSIGN, Nevada GERALD L. KLECZKA, Wisconsin
JON CHRISTENSEN, Nebraska JOHN LEWIS, Georgia
PHILIP M. CRANE, Illinois XAVIER BECERRA, California
AMO HOUGHTON, New York
SAM JOHNSON, Texas
Pursuant to clause 2(e)(4) of Rule XI of the Rules of the House, public hearing records
of the Committee on Ways and Means are also published in electronic form. The printed
hearing record remains the official version. Because electronic submissions are used to
prepare both printed and electronic versions of the hearing record, the process of converting
between various electronic formats may introduce unintentional errors or omissions. Such occur-
rences are inherent in the current publication process and should diminish as the process
is further refined.
(II)
CONTENTS
Page
Advisory of January 21, 1998, announcing the hearing ....................................... 2
WITNESSES
Health Care Financing Administration, Hon. Nancy-Ann Min DeParle, Ad-
ministrator ............................................................................................................ 7
U.S. General Accounting Office, William J. Scanlon, Ph.D., Director, Health
Financing and Systems Issues, Health, Education, and Human Services
Division; accompanied by Leslie Aronovitz, Associate Director, Health Fi-
nancing and Systems ........................................................................................... 41
(III)
PREPARING THE HEALTH CARE FINANCING
ADMINISTRATION FOR THE 21ST CENTURY
HOUSE OF REPRESENTATIVES,
COMMITTEE ON WAYS AND MEANS,
SUBCOMMITTEE ON HEALTH,
Washington, DC.
The Subcommittee met, pursuant to notice, at 10:08 a.m., in
room 1100, Longworth House Office Building, Hon. William Thom-
as (Chairman of the Subcommittee) presiding.
[The advisory announcing the hearing follows:]
(1)
2
3
4
was the rule not the exception. And as any of you who have tried
to get past 800 numbers to check your credit card know, Im not
sure whether money will solve all those problems. But I do know
that these plans will be complex they will be confusing. Our own
offices will hear from beneficiaries and we ought to do whatever we
can: one, to encourage HCFA to see that the phones are answered
promptly and there are people who can give you good information,
and secondly, that we see that they get the resources to be able to
do it.
Finally, you asked, Mr. Chairman, whether HCFAs reorganiza-
tion produced a structure that is appropriate for the 21st century;
and Im afraid it isnt. Weve got a situation like weve hadand
criticized oftenwithin the FAA. HCFA is in the business, or will
be in the business, of promoting managed care at the same time
it is trying to regulate it. And those are conflicting roles. You cant
order people to promote something on the one hand, and then on
the other hand come back and say youve got to investigate them
and tell people when they arent working correctly. I think we have
to look at that issue and look for independent patients counsel, or
separating, if not explicit, implicit promotion of managed care and
its regulation.
While the Cshairman may not like the ideas for regulations that
are currently being circulated, we do need them. Weve got to stop
the cheers in the movie As Good As It Gets and somehow make
the public convinced that they do have somebody on their side. And
I hope our Subcommittee will look at that important issue.
Thank you for starting out the year with this hearing and I look
forward to hearing from our witnesses.
Chairman THOMAS. I thank the gentleman.
This is a new year and a second session and I believe the spirit
in which the gentleman made his comments is a constructive one
and I did not go into any detail in my opening remarks rather than
to just set the frame. I think youll find, and now I guess Ill
prompt our first witness, that our intention was to make sure that
there was adequate funding for the administrative changes. We
have tried to work in a cooperative way to make sure that if nec-
essary the movement of money within the structure, and indeed
additional money, could be made available. I had no intention
whatsoever of creating new ways to deliver services and then not
make sure they werent adequately financed to do that. You and I
could share some time discussing the appropriators and the way in
which all of us have concerns about the appropriators.
Beyond the gentlemans concern for an organization thats not
only going to regulate managed care but also supervise and run it,
the same might be true for fee-for-service, and in fact they have al-
most a monopoly on that. We will have panelists who have looked
at this problem and who have the same concern from adjustment
within the culture of HCFA to eliminating HCFA. And I just think
its appropriate at this stage, maybe, to remember that the Presi-
dent has played a relatively significant role in getting us to refocus
on the question of health care delivery in Medicare and in putting
people first.
On page 21, the President said as part of his vision, if he were
to be elected president, quote, We will scrap the Health Care Fi-
7
beneficiaries in your district that none of you are going to get this
anymore, because that is not the case. If they are qualified, if they
are homebound and they need skilled or intermittent nursing care,
they will be qualified for this benefit. The people who will no longer
be qualified are simply those who only need their blood drawn, and
the actual drawing of the blood of course will continue to be cov-
ered by Medicare.
And we do want to work with you, sir, to monitor the situation
and make sure that beneficiaries who need this service are con-
tinuing to get it. And I hope once this confusion is cleared up, that
problem will not be as apparent any more.
Mr. LEWIS. Thank you. Let me ask you another question. Nearly
40 percent of the end-stage renal disease population are African-
American, even though we make up only about 11 percent of the
population. It is my understanding that the outcome for the Afri-
can-American end-stage renal disease population is not as good as
with other populations. Could you comment on this situation? What
steps could you take that might improve this situation?
Ms. DEPARLE. Im not as familiar with the situation on end-stage
renal disease, sir, but I do know that in many of the health indica-
torshealth status indicatorsthat we look at for our population,
we find that African-American beneficiaries dont get the services
they need as often. Immunizations is an example; flu shots; mam-
mograms. In many of those areas, we find that that community is
not as well served.
We are working in partnership with historically-Black colleges
and universities around the country to try to do some focused cam-
paigns to reach that population. And I might also add that weve
been talking today about HCFAs reorganization, and one aspect of
that that I think is positive for our ability to do a better job here
is that weve created for the first time a center for beneficiary serv-
ices. That center will be the one conducting the beneficiary infor-
mation campaign. And one of their goals is to try to make sure that
they do things not just for the population as a whole, but that they
try to figure out what the best ways are to reach other populations
that may be particularly needy or vulnerable so that, with the new
preventive benefits that Congress just enacted that are very posi-
tive, we can make sure that our African-American beneficiaries re-
ceive the full promise of those new benefits.
Mr. LEWIS. I appreciate you responding. I look forward to work-
ing with you.
The Surety Association of America has reported that the way
home health agency surety bond regulations have been written,
their members are unwilling to write bonds. Will you describe for
the committee your understanding of the situation and what will
be done to resolve this issue before the bond due date of February
27?
Ms. DEPARLE. Well, as you know, Mr. Lewis, this provision that
we are talking about here is the new surety bond provision that
was enacted in the Balanced Budget Act, and it gives us the ability
to require a home health provider to post a surety bond so that if
Medicare is defrauded that Medicare will have some ability to re-
cover from them. And that is a good step forward. Thats been done
in the State of Florida, and it has had a very good result.
28
do that. That has not been something that has been allowed in the
past. So thats what private contracting is. This is different. This
is saying that a Medicare-eligible veteran or military retiree could
chose a health plan that is provided by DOD or VA.
Mr. SAM JOHNSON of Texas. Or a doc.
Chairman THOMAS. No, let me interject again, and I apologize.
But when I used the term contracting, it was contracting out its
managed care services. It is a requirement, pretty obviously, in a
military hospital that if youre going to treat Medicare-eligible pa-
tients, you have to be able to offer those services that are part of
the Medicare package. If the military hospital does not have the
ability to deliver all of those aspects of the required Medicare pack-
age, they can contract out for those aspects. But it is primarily en-
visioned as contracting out to those entities in those communities
where there are military retirees that do this on an ongoing basis
with ordinary Medicare beneficiaries. So it would be contracting
out, but it is primarily managed care services. But Id be willing
to sit down with the gentleman and go over what I consider to be
some relatively positive innovative approaches already underway at
the DOD and the possibility of beginning at the Veterans Adminis-
tration to make sure that his concerns, if at all possible, could be
addressed in the way in which the demonstration is designed.
Mr. SAM JOHNSON of Texas. Thank you, I appreciate that. You
know, I would just like to know your views on that too, because pri-
vate contracting is private contracting, you know, any way you cut
it.
Chairman THOMAS. I understand that. And given the gentle-
mans background and current status, hes a practitioner and I
want to listen to him.
Mr. SAM JOHNSON of Texas. Well, I tell you what, the guys in
the military complain about the system and the way its operating.
And we need to protect them. And thats part of HCFAs job, I be-
lieve.
Ms. DEPARLE. Wed like to work with you on the demonstration
and with the committee.
Mr. SAM JOHNSON of Texas. Thank you, maam. And thank you,
Mr. Chairman.
Chairman THOMAS. Thank you very much.
The gentleman from Maryland.
Mr. CARDIN. Thank you, Mr. Chairman.
And let me welcome you here in your new responsibility. This is
your first appearance, I believe, and we look forward to working
with you, following up on last years work of this committee in try-
ing to improve the Medicare system and the other areas that fall
under your responsibility. It is a pleasure to have you here.
I just want to make a comment about one of Mr. Johnsons state-
ments, and that is I know we got a little bit off on the private con-
tracting, but it is my understanding that you have sent notices to
all physicians indicating that if its a non-covered service there is
no need for a private contract. And that notice has gone out.
Ms. DEPARLE. Yes, we did. That went out in November, and we
sent it out to all the physicians in the country.
Mr. CARDIN I want to change gears and talk about the prudent
lay persons standard for emergency care. And we very much ap-
32
very best to see that we are timely. And I wasnt aware that there
were two-dozen reports that were overdue. I am very aware of the
Medicare Select Report, and have personally reviewed it, and I
hope that we will be able to get it to you soon. I believe that one
was due on December 31, so we are behind on that.
Mrs. JOHNSON of Connecticut. Yes, it was. Thank you very much,
I look forward to seeing that move. I assume thats out of your shop
at this point, since you have reviewed it?
Ms. DEPARLE. I believe it is.
Mrs. JOHNSON of Connecticut. Is it then at OMB?
Ms. DEPARLE. Yes, I believe thats where it is.
Mrs. JOHNSON of Connecticut. Well, well certainly look forward
to the completion of this work. And any way we can help you, were
happy to because I believe timeliness is important. And its a big
problem. I chair the Oversight Subcommittee of the IRS. I can tell
you, they are much further behind than you are.
Chairman THOMAS. Thats not a compliment.
Ms. DEPARLE. I know that.
Mrs. JOHNSON of Connecticut. Its like justice delayed is justice
undone, you know. If we dont keep the flow of information going
we dont win. And I see, unfortunately, my time has expired, be-
cause I do want to just point out to you the terrible problem were
having with dual-eligibles. And I see you are reorganizing in a way
that will create a more one-stop shopping approach to managed
care and fee-for-service policy, but we really have to look at the
dual-eligibles and I think we have to look at what I consider to be
a real rip-off of Medicare: the Medicare maximization program. The
States are spending tons of money on this. They are squandering
their resources and ours on all the legalities. The home health
agencies are really disadvantaged by the problem of going back for
these records, of copying them, of reviewing them. Its really a trag-
edy. And when the whole system is under so much pressure to re-
duce costs, deliver quality services, I think we need to sit down
about that Medicare maximization program and come to terms
with it and settle it out, which we can do and we started doing
three years ago, and it still isnt completed. Then that folds right
into the dual-eligible project that weve got to start piloting in some
of the states in order to give better service to low-income seniors,
but also reduce the cost for federal and state government. So Id
like to work on that project with you.
Ms. DEPARLE. Ill look forward to working with you on it.
Mrs. JOHNSON of Connecticut. Thank you very much.
Chairman THOMAS. Its my pleasure to indicate that a Member
who is not a member of this subcommittee is with us today. He is
a freshman Member of Congress, but I have a hunch that one of
the reasons hes more interested in this is not in that capacity, but
because he is a medical doctor, doctor of ophthalmology. Gentleman
from Louisiana, Mr. Cooksey, I assume wishes to inquire.
Mr. COOKSEY. Thank you, Mr. Chairman. And Ms. DeParle, wel-
come to the committee. This is my first committee meeting too.
Im on the Health Subcommittee of Veterans Affairs, and theres
a lot of confusion about some of the overlap here.
My questionthe question I would like for you to answerand
Im going to drive toward thatis, do you ever step back and look
35
at the overall picture? There are a lot of programs that are govern-
ment paid, that are government financed. Theres Medicare, theres
Medicaid, there are veterans hospitals. Incidentally, Ive asked the
same questions in my health subcommittee.
There are many providers, there are many recipients. There
must be some duplication occasionally. I personally think theres a
lot of duplication, a lot of overlap. And I think there are a lot of
regulators and a lot of regulations, and these solutions have always
been done piecemeal to solve some problem. And its been my im-
pression when I was out in the private sector that theres been a
lot of micromanagement by people in the bureaucracy, like yourself;
a lot of lawyers, a lot of people that are in government, that are
micromanaging the problems as they come up.
But I feel that we do need to eliminate this duplication. We need
to downsize some of the bureaucracies. We definitely need to re-
duce the cost. And the way to do that is by quality health care.
When you have really quality health care, a patient wont have to
go back to have the same procedure repeated because it was not
done right the first time, and that will reduce cost.
But my question is, is there anyone that is out there that ever
steps back, and looks at the overall picture, and say, gee, who is
representing the patients?
When the Balanced Budget bill was coming through, there was
a firestorm of activity. You were not here then, I know. But there
was every group being represented, except the patients, I feel.
There were bureaucrats here, there were the managed care people,
there were the insurance companies, there was organized medicine,
there were physicians, there were specialists, home health, and
yes, even the trial lawyers. But they were there ad infinitum. But
nobody really seemed to be representing that patient that is out
there in some rural area or some inner city metropolitan area that
truly needed health care. And youve got a lot of special interest
groups that are still micromanaging things for their best interest.
What is your agency doing to look at the big picture, and to real-
ly address the number one stakeholder, the patient?
Ms. DEPARLE. Well, I think one thing weve done, and I described
it at the beginning of my statement, was, our reorganization was
partly designed to try to get at those questions of, are we serving
beneficiaries, and how do we organize ourselves so that were
thinking more about beneficiaries. That is why we created this
Center for Beneficiary Services.
If we had not done that reorganization, the new Medicare Plus
Choice Plan and the information campaign that were going to do
this year, those activities of providing the information, and the toll
free lines, and the things that the Congress has asked us to do to
interact with beneficiaries, would have been in five or six different
locations within HCFA. Now we have centered in one place an or-
ganization that is designed to look at that.
I also think in respect to your comment about the veterans area,
thats actually an area about which I think the Congress can feel
good trying to look at whats best for the beneficiary, as opposed
to how do these structures in Washington work. And the reason I
say that, is because what that demonstration is designed to look at
is, if you are a veteran and you are Medicare eligible, why
36
tem, which I believe has finally been owned up to. And in your
written testimony, Ill refer to once again, a clear indication that
you have finalized the contract with that, and that perhaps the
concept at some time may have had a degree of viability, but it is
no longer the case.
Ms. DEPARLE. Thats right.
Chairman THOMAS. Youre looking for another way or perhaps a
fundamental rethink of the way of dealing with the tracking sys-
tem, is that correct?
Ms. DEPARLE. Thats right.
Chairman THOMAS. Would you consider youre entering into, fill
in the blank, a $50 million, $70 million effort, which has really pro-
duced nothing, a kind of a failure, or did we learn something out
of it?
Ms. DEPARLE. Well, I think we learned something; it was pain-
ful. I think we learned what a lot of private sector companies have
learned, that a big effort like that was too big and too risky.
Chairman THOMAS. And I guess then, were involved with ques-
tions of judgment; how things get started, how they get perpet-
uated, where you make decisions, where you stop. In private sector
when you have failures of that magnitude, usually someones out
of a job.
My concern is, that for the last several years younot you, the
agencyhas been run on a kind of a pass/fail basis, and Im just
wondering if anybody failed on the pass/fail judgment, based upon
this multimillion dollar program that has now been completely ter-
minated, with very little residual benefit?
Ms. DEPARLE. Well, I think, as you know, Mr. Chairman, be-
cause you visited us, we have a lot of talented people at the Health
Care Financing Administration, and theyre all committed to trying
to do the best job they can for our beneficiaries. And I think that
everyone who was working there learned a lesson from the Medi-
care transaction system, and we arent going to do it that way
again.
Chairman THOMAS. Has anybody received a failure on any of
those evaluations on a pass/fail basis in terms of the staff at
HCFA?
Ms. DEPARLE. I dont know the answer to that. I do know that
most of our employees, since that pass/fail system was initiated,
have received a pass. I havent looked through the 3,000 or so eval-
uations to see how many of them got a failure. There have been
some failures. I dont know if they were connected with that par-
ticular program.
Chairman THOMAS. And I dont want anyone to assume by my
line of questioning that I dont think that there arent a lot of tal-
ented hardworking people over there. Its just that when youre
dealing with a fundamental change in the direction and culture of
a bureaucracy, you have to look at your ability to be flexible in
dealing with employment, and frankly, to make changes.
My concern is, the manner in which employees are evaluated,
probably doesnt give you a sufficient ability to make decisions, ex-
cept that you probably, as is the case when the formal monitoring
structures not adequate, you do it in an informal way, which is the
way we want to do it, because then that can be argued to be subjec-
39
And when you answer the question, please tell us whether under
an MSA Medicare product physicians or providers, generally, must
bill according to the Medicare fee schedule or are they allowed to
bill higher than 115 percent of the Medicare fee schedule?
Ms. DEPARLE. Well, Im happy to report that the MSA dem-
onstration project, our plans for that are on track. And in fact, I
believe weve done some briefings of some of the committee staff on
that, and we have been working with the folks at the Treasury De-
partment, who have done a similar demonstration as you know in
the private sector.
With respect to the balance billing limits, I believe that they
would not apply, because the whole concept of an MSA is to have
the beneficiary bearing more of the cost, and the idea is supposed
to be that they will then be more sensitive to cost. And I believe
that in that demonstration they will be, so to speak, on their own.
Mr. MCCRERY. Thank you.
Chairman THOMAS. Gentleman from Maryland, a brief interven-
tion.
Mr. CARDIN. Thank you.
One additional point under BBA that I just want to bring to your
attention, that is the GME payments to quality non-hospital pro-
viders gives you an opportunity for the first time to move into a
somewhat different area. What were concerned about is that we do
have some public health departments that would be interested in
looking at establishing residencies in public health that could help
us in this area. Its probably not going to be allowed because they
dont have contracts under Medicare.
But I would ask that you would take a look and work with us
as to whether it would be worthwhile to look at a demonstration
in this area. And I just really wanted to bring it to your attention,
and hope that we could work in that area.
Thank you, Mr. Chairman.
Mr. STARK. Could I follow up?
Chairman THOMAS. This is a first, not a last. So if anybodys got
anythingshes going to be back. Go ahead.
Mr. STARK. Well, I just wanted to follow up on the question that
Mr. McCrery asked regarding Medicare MSAs. I understand how
that works when beneficiaries are spending their own deductible
lets say its a $2,000 deductible. But after that, would Physicians
not then be required to, bill Medicare under the standard proce-
dure? Would the balance billing limits apply? Would the Medicare
DRGS be applicable?
Maybe you could enlighten me there? After the out-of-pocket-de-
ductible is spent.
Ms. DEPARLE. I understand your question, Mr. Stark, and I know
that this came up a month or so ago, and our Office of General
Counsel was looking at it. And if I could, Id like to get back to you
for the record on it, because I dont want to say the wrong thing
here. But I do understand the subtlety of your question.
Mr. MCCRERY. Could you copy me on that?
Ms. DEPARLE. Oh, certainly.
Mr. STARK. Yes. I mean, I
Chairman THOMAS. Would you submit it to the subcommittee?
Mr. STARK. Yeah, that is
41
Chairman THOMAS. Thank you very much. Thank you very much
Dr. Scanlon, Ms. Aronovitz. No additional questions. Well be call-
ing on your expertise and your organization in the near future.
Last panel for today: Stuart Butler, whos obviously been before
us in the pastwe look forward to his testimonythe Heritage
Foundation. Dr. Paul Ginsburg. And its pleasant to find out that
other folk whove been studying the concerns that we have as well,
if not in direct context, at least in a general context, that Dr. Mi-
chael Gluck, National Academy of Social Insurance, and Marion
Lewin, who was the study director of a Committee on Choice and
Managed Care, Institute of Medicine.
I want to thank all of you for coming. Your written testimony
will be made a part of the record, and you can address us in your
timeframe as you see fit. And well start with Dr. Butler. Thank
you.
STATEMENT OF STUART BUTLER, VICE PRESIDENT, DOMES-
TIC AND ECONOMIC POLICY STUDIES, THE HERITAGE FOUN-
DATION
Mr. BUTLER. Thank you, Mr. Chairman.
Congress last year enacted a series of reforms that modernized
Medicare, as you mentioned in your opening statement. If HCFA
is to carry out its new role under these reforms, it must respond
to two challenges. It must be able to organize a market of com-
peting health plans and provide the information necessary for
beneficiaries to make wise choices within that market; and it must
make the traditional fee-for-service system a more effective compet-
itor to managed care and other private plans that are available
now to beneficiaries.
Broad economic and managerial principles would suggest two key
strategies are needed to respond to these challenges. First, the
management of the market of competing plans and the provisions
of information to consumers must be completely separate from the
operation of any particular plan. That is a very basic principle of
economic organization in a market. Those responsible for setting
the rules of competition, and for providing consumers with dis-
passionate information on rival products, should have neither an
interest in promoting any particular product, nor even the close re-
lationship with one of the competitors. That is why umpires in
baseball do not own baseball teams. But HCFA today carries out
both of these conflicting functions.
Second, the managers of an in-house government plan in a com-
petitive market should be given wide latitude to introduce innova-
tions in organization and marketing. But today, as I note in my
testimony, there are several obstacles that frustrate efforts by
HCFA managers and staff to make the traditional fee-for-service
plan more competitive and better attuned to the customer needs
and desires.
With this in mind, I believe Congress should make two major or-
ganizational changes in Medicare. One, Congress should create a
Medicare Board responsible directly to the secretary of HHS. In ef-
fect, Congress should create within HHS a body that is the func-
tional equivalent of the Office of Personnel Management within the
FEHBP. The function of this body and the focus of the staff within
63
that we have got to separate that. We cannot have the fox in the
hen house. Does that comport with your concerns? If we are going
to contract with outside groups, basically private groups, to do
quality investigations for us, there should just be an absolute pro-
hibition between any contact with that company and the people
that are investigating.
Mr. BUTLER. Im not an authority on the structure NCQA, so I
would hesitate to talk in detail about that. I would say that your
general principle is one I would agree with as a general matter,
namely that for those who set the rules of the game that will affect
any particular player should, at the very least, any involvement
should be very explicit and clear and taken into account. Ideally,
the people involved should not have a direct interest in the out-
come of any of those decisions, I think as a general principle.
Now there is also of course the issue of an advisory role. It
makes a lot of sense to have people who are practical players in
a field to give advice and to make recommendations and so on. But
that can be separated from the ultimate authority of who makes
the decision.
Mr. STARK. Thank you. I, by the way, just as a sidebar, like your
idea of a board to manage the Medicare managed care plan. I
would love to discuss that with you further at some other time. I
think we have to do something in that area.
Either Dr. Gluck, or Paul Ginsburg, could respond to this. We
now reimburse virtually any hospital that wants to conduct a
transplant operation, even though common wisdom would suggest
that those centers which do many more procedures have far better
outcomes.
Would you all support giving HCFA the authority to narrow the
number of facilities for certain complex procedures so that we con-
centrate experience? I hate to use the words centers of excellence,
because Im not sure how you define that. But, these centers that
have more experience, would we not be doing a service by giving
HCFA the authority to direct patients to them?
Mr. GLUCK. The study panel spent a fair amount of time looking
at the examples from private health insurance, in which patients
are steered toward those providers that do better in cost and qual-
ity outcomes. The panel was struck by that, and it certainly in-
forms their recommendations. They didnt get into a lot of the spe-
cifics about exactly how that would be done.
Mr. GINSBURG. Clearly, one of the innovations that we can imag-
ine would be HCFA identifying for beneficiaries the best transplant
providers and were contracting with them. We did not discuss
whether the ones that do not make that cut should not be in the
program or they shall just hold non-preferred status. But it clearly
is in the programs interest to steer beneficiaries toward more effec-
tive providers.
Mr. STARK. You also talk about the practice patterns that are
identified in the Dartmouth Atlas. Somebody recently indicated
I think it was Uwe Reinhardt in his Christmas cardthat a proce-
dure that costs $8,000 fees in Miami is only $3,000 in Minneapolis.
Now I have a plan to contract with Northwest Airlines. We could
do a lot of flying people back and forth from Miami to Minneapolis
and save a lot of money, it seems to me, in between. But all I have
114
been able to find is that these huge differences in the cost of care
where the outcomes dont reflectthe cost, is tradition. These dif-
ferences are habit. They are a whole host of things which Im not
sure Congress can control.
But I would hope that you could help us in finding some way
that we could begin to move toward some national standards. With
two and a half and three times a difference for the same proce-
dures with equally highly qualified and well-trained providers, we
are going to have a problem that is just going to intensify if we
cant figure out a way tolevel that out.
Mr. GINSBURG. Yes, these variations demonstrate the potential
for saving money and improving quality by moving beneficiaries to-
wards where the best care is delivered. A number of implications
for the Pands ideas come up. One is that if a certain procedure
costs $8,000 in Miami and $3,000 in Minneapolis, we should con-
centrate our efforts improving its delivery in Miami, but not in
Minneapolis, because I wouldnt rule out a Medicare program to
provide an option for beneficiaries to travel to a facility that has
a contract with HCFA to provide these services on the basis of its
quality and cost.
Mr. STARK. The airlines will be after us. Thank you, Mr. Chair-
man.
Chairman THOMAS. Just briefly along that line, I think its fairly
easy to talk about the best move to quality and the rest. The dif-
ficulty I have is coming up with a really objective way to measure
some of that. The best way I know is to collect the data statis-
tically, create outcomes, compare outcomes for dollar spent, and
begin to structure it in a way that allows you to at least define
quality in a relative sense. Especially to determine what you get
for your dollar. And then create some positive guidelines.
I have a very real concern, this is slightly off the mark, but clear-
ly an issue we have to deal with is the ability to gather that infor-
mation, the question of confidentiality, the ability to produce with
clear protections for folk where its appropriate, the material nec-
essary to produce the outcomes research to provide the positive
guidelines given the potential of some legislation which will limit
us. Minnesota has been mentioned several times. Over the break,
I spent some time at the Mayo Clinic talking with them. Their real
concern, for example, the new Minnesota State law in the ability
to collect information. The whole question of information collection
as a matrix for making decisions, both of cost effective and of qual-
ity will be absolutely critical to us to be able to do the kinds of
things you have been discussing. Its an area that all of us have
to deal with because a very simple bill passing will eliminate our
ability to move in a number of directions that would produce qual-
ity medical care at a reasonable cost to taxpayers.
The gentleman from Louisiana?
Mr. MCCRERY. Thank you, Mr. Chairman. Actually, you asked
most of the questions that I was going to ask.
Dr. Butler, if the title of this hearing had been preparing Medi-
care for the 21st century rather than preparing HCFA for the 21st
century, would you have submitted different testimony?
Mr. BUTLER. Well, I would have commented probably on the de-
fined contribution issue, as I have done before. But I think the
115